Seagen is based out of Bothell. Discovers and develops monoclonal antibody-based therapeutic products for the treatment of cancer and immunologic diseases. As of Dec. 31, 2004, the company had three product candidates in clinical trials: SGN-30 (lymphoma); SGN-15 (non-small cell lung cancer); and SGN-40 (multiple myeloma).Whalewisdom has at least 3 13D filings, 2 13G filings, and 420 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2009-06-01. The notice included securities offered of Equity
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
Seagen Inc.21823 30TH DRIVE SE
BOTHELL WA 98021
Business Phone: 4255274000
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)